Skip to content
Clinical Trials – home

Thiocolchicoside: A Comprehensive Guide for Patients

1 / 3
trials open to patients / all trials
3+
Countries

In short

Thiocolchicoside is a muscle relaxant drug that has been the subject of several clinical trials, particularly for its potential in treating various types of pain. These studies have explored its efficacy in conditions such as low back pain, neck pain, and temporomandibular disorders. The trials have investigated different formulations of thiocolchicoside, including oral tablets, injections, and topical applications, often in combination with other pain-relieving medications.

At a glance

Primary Uses
Treatment of acute low back pain, neck myofascial pain, temporomandibular disorders
Administration Methods
Oral tablets, intramuscular injections, topical ointments
Combination Therapies
Often combined with NSAIDs (e.g., ketoprofen, diclofenac) or used in mesotherapy
Outcome Measures
Pain scales (VAS), mobility assessments, disability questionnaires, quality of life measures
Study Designs
Randomized controlled trials, comparative studies with other treatments
Dosages (examples)
4 mg twice daily (oral), 8 mg intramuscular
Treatment Duration
Varies by study, ranging from single administration to several weeks
Special Applications
Explored in dental procedures, irritable bowel syndrome treatment

What is Thiocolchicoside?

Thiocolchicoside is a medication primarily used as a muscle relaxant and anti-inflammatory agent. It is often prescribed to patients experiencing muscle spasms or pain associated with various musculoskeletal conditions. Thiocolchicoside is known by several other names, including Muscoflex, which is one of its brand names.

Medical Conditions Treated

Thiocolchicoside is used to treat several medical conditions, including:

  • Acute Low Back Pain: This is one of the most common conditions for which thiocolchicoside is prescribed. It helps relieve pain and improve mobility in patients suffering from sudden onset of lower back pain.
  • Neck Myofascial Pain Syndrome: This condition involves pain in the muscles and fascia (connective tissue) of the neck. Thiocolchicoside has been studied for its effectiveness in treating this type of pain.
  • Facial Myalgia: This refers to muscle pain in the face, often associated with temporomandibular joint (TMJ) disorders. Thiocolchicoside has been used as part of treatment regimens for this condition.
  • Irritable Bowel Syndrome (IBS): While not a primary treatment, thiocolchicoside has been included in some experimental therapies for IBS, particularly when administered through mesotherapy (injections into the middle layer of skin).

How Thiocolchicoside Works

Thiocolchicoside functions as a muscle relaxant. It works by reducing muscle tension and spasms, which in turn helps to alleviate pain and improve mobility. By relaxing tense muscles, it can provide relief from various musculoskeletal conditions, particularly those involving the back and neck.

Administration Methods

Thiocolchicoside can be administered in several ways, depending on the specific condition and treatment plan:

  • Oral tablets: Often prescribed as 4 mg or 8 mg doses, taken twice daily.
  • Intramuscular injections: Used in some cases for quicker relief, particularly in acute low back pain.
  • Topical application: Thiocolchicoside ointment has been studied for use in cervical myofascial pain syndrome.
  • Mesotherapy: In some experimental treatments, thiocolchicoside is administered through small injections into the middle layer of the skin.

Combination Therapies

Thiocolchicoside is often used in combination with other medications to enhance its effectiveness:

  • With Non-Steroidal Anti-Inflammatory Drugs (NSAIDs): Combinations such as thiocolchicoside with ketoprofen or dexketoprofen have been studied for their combined pain-relieving and muscle-relaxing effects.
  • With Analgesics: Combinations with pain relievers like paracetamol have also been investigated.
  • In Mesotherapy Cocktails: Some experimental treatments combine thiocolchicoside with other substances like mesocaine, amitriptyline, and magnesium pidolate for mesotherapy injections.

Clinical Studies and Effectiveness

Several clinical studies have been conducted to evaluate the effectiveness of thiocolchicoside:

  • A study compared the combination of thiocolchicoside and ketoprofen to thiocolchicoside alone for acute low back pain, aiming to demonstrate the superiority of the combination.
  • Another trial assessed different regimens of thiocolchicoside injection and capsule, combined with either diclofenac or ibuprofen, for acute low back pain.
  • The efficacy of topical thiocolchicoside was studied in cervical myofascial pain syndrome, comparing it to trigger point injections.
  • A study evaluated the effects of thiocolchicoside in combination with other drugs on temporomandibular disorders.

These studies generally aim to measure pain reduction, improvement in mobility, and overall patient satisfaction with the treatment.

Potential Side Effects

While specific side effects were not detailed in the provided clinical trial information, it's important to note that all medications can have potential side effects. Common side effects of muscle relaxants like thiocolchicoside may include drowsiness, dizziness, or gastrointestinal discomfort. Always consult with your healthcare provider about potential side effects and report any unusual symptoms you experience while taking this medication.

Questions people often ask

Conditions where Thiocolchicoside is being studied

Each condition opens its own overview and trial list

Trials with Thiocolchicoside

Recruiting trials first

See all 3 →
Quick filters
  • Participants:Adults
  • Participants:Adults
  • Participants:Adults
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).